Dr. Sami Dahdal, MD

Dr. Dahdal practices at Lawrence + Memorial Hospital in New London, Connecticut, part of Yale New Haven Health System.

Dr. Dahdal's NPI, 1700316668, was assigned on June 14, 2017. Dr. Dahdal holds Connecticut license 65170.

Dr. Dahdal's primary practice is Lawrence + Memorial Hospital, at 365 Montauk Ave, New London, CT 06320 in New London County. The practice phone is (860) 442-0711.

Dr. Dahdal's primary practice is Lawrence + Memorial Hospital in New London, Connecticut, part of Yale New Haven Health System. Dr. Dahdal is also affiliated with Rhode Island Hospital. The medical group on file is Hospital Medicine Associates. Dmand AI also links Dr. Dahdal to 3 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dahdal practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dahdal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Dahdal is licensed in Connecticut.

CMS data shows 707 Medicare services from Dr. Dahdal across 5 procedure codes in 2024, for 452 Medicare patients. Medicare paid $72,394 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 452 Medicare patients who saw Dr. Dahdal in 2024. The largest group is 75 to 84, with 161 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dahdal's median patient age at 70, with 50% women.

In 2024, Dr. Dahdal wrote 188 Medicare Part D claims for 82 patients. 88% of them were for generic drugs. CMS names the drug for 44 of them, across 3 drugs with 11 or more claims each, at $206 in total drug cost. In 2022, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Dahdal for performance year 2024, reported as part of a group. Dr. Dahdal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Dahdal, published from 2018 to 2020. 2020 was the busiest year, with 2. Dr. Dahdal has published most often in ACG Case Rep J. Dr. Dahdal's most frequent co-authors are Natalia Khalaf, MD, Karen Shaoyi Jiang and Ashwin Srivatsav.

CMS Open Payments shows 8 general payments to Dr. Dahdal from 6 drug and device companies from 2019 to 2021. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $164.